CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Hoge Stephen President | Sale 10b5-1 | −304 | $86.23 | $26K | 1,516,281 |
| 2024-02-09 | Hoge Stephen President | Exercise or conversion 10b5-1 | +522 | 1,516,585 | ||
| 2024-02-09 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −522 | 2,090 | ||
| 2024-01-16 | Hoge Stephen President | Sale 10b5-1 | −15,000 | $103.90 | $1.6M | 1,516,063 |
| 2024-01-08 | Mock James M Chief Financial Officer | Sale 10b5-1 | −772 | $109.75 | $85K | 3,632 |
| 2024-01-05 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +1,452 | 4,404 | ||
| 2024-01-05 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,452 | 15,980 | ||
| 2023-12-27 | Hoge Stephen President | Sale 10b5-1 | −45,000 | $100.01 | $4.5M | 1,531,063 |
| 2023-12-08 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −563 | $79.09 | $45K | 7,912 |
| 2023-12-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +1,139 | 8,475 | ||
| 2023-12-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,139 | 6,832 | ||
| 2023-12-06 | Garay Arpa Chief Commercial Officer | Sale 10b5-1 | −564 | $78.34 | $44K | 3,690 |
| 2023-12-05 | Garay Arpa Chief Commercial Officer | Exercise or conversion 10b5-1 | +1,141 | 4,254 | ||
| 2023-12-05 | Garay Arpa Chief Commercial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,141 | 11,405 | ||
| 2023-12-04 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −111 | $79.31 | $9K | 7,336 |
| 2023-12-04 | Hoge Stephen President | Sale 10b5-1 | −309 | $79.31 | $25K | 1,576,063 |
| 2023-12-01 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +232 | 7,447 | ||
| 2023-12-01 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −232 | 2,094 | ||
| 2023-12-01 | Hoge Stephen President | Exercise or conversion 10b5-1 | +651 | 1,576,372 | ||
| 2023-12-01 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −651 | 5,865 |
Page 36 of 38 · 743 trades